Financial Sense Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-8,725
Closed -$756K 151
2026
Q1
$756K Buy
8,725
+88
+1% +$8.43K 0.15% 86
2025
Q4
$830K Buy
8,637
+5
+0.1% +$486 0.15% 82
2025
Q3
$822K Sell
8,632
-330
-4% -$30.3K 0.14% 92
2025
Q2
$781K Sell
8,962
-77
-0.9% -$6.53K 0.18% 78
2025
Q1
$812K Buy
9,039
+358
+4% +$32K 0.23% 65
2024
Q4
$693K Sell
8,681
-93
-1% -$8.05K 0.23% 66
2024
Q3
$790K Sell
8,774
-35
-0.4% -$2.94K 0.21% 68
2024
Q2
$693K Buy
+8,809
New +$722K 0.21% 76
2018
Q4
Sell
-27,539
Closed -$2.71M 59
2018
Q3
$2.71M Buy
+27,539
New +$2.55M 1.14% 17
2015
Q3
Sell
-66,155
Closed -$4.9M 99
2015
Q2
$4.9M Sell
66,155
-1,023
-2% -$78.2K 2.28% 13
2015
Q1
$5.24M Buy
67,178
+18,439
+38% +$1.4M 2.19% 12
2014
Q4
$3.52M Buy
48,739
+294
+0.6% +$20.4K 1.42% 27
2014
Q3
$3M Buy
+48,445
New +$3.08M 1.28% 31

Other funds holding MDT

Financial Sense Advisors's MDT Position: Q2 2026 in Review

Financial Sense Advisors sold out of Medtronic (MDT) in Q2 2026, closing a stake of 8,725 shares — an estimated $756K sold.

Financial Sense Advisors first reported a position in MDT in Q3 2014 and held it in 13 quarters. The position peaked at $5.24M in Q1 2015. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Financial Sense Advisors reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Financial Sense Advisors sold 8,725 Medtronic shares in Q2 2026, an estimated $756K.
  • Financial Sense Advisors first reported a position in Medtronic in Q3 2014 and held it in 13 quarters.
  • Financial Sense Advisors's Medtronic position peaked at $5.24M in Q1 2015.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Financial Sense Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.